Literature DB >> 12767845

Bacteriological, clinical and epidemiological characteristics of hospital-acquired Acinetobacter baumannii infection in a teaching hospital.

M Ayan1, R Durmaz, E Aktas, B Durmaz.   

Abstract

Over an 18 month period, the bacteriological, clinical and epidemiological characteristics of nosocomial Acinetobacter baumannii infections in a teaching hospital were studied. Typing studies were performed on 38 strains isolated from 36 patients. Twenty-two of the strains were isolated during the three outbreaks. Surgery, catheterization, mechanical ventilation, and antibiotic therapy for adult patients and respiratory distress syndrome, mechanical ventilation, and prematurity for paediatric patients were the main risk factors identified. All isolates were resistant to penicillins (except ampicillin-sulbactam), cephalosporins, gentamicin, and aztreonam but susceptible to carbapenems and colistin. Resistance to tobramycin, ciprofloxacin, ampicillin-sulbactam, trimethoprim-sulfamethoxazole, and amikacin was variable. Antibiotyping, arbitrarily-primed polymerase chain reaction (AP-PCR) and the pulse-field gel electrophoresis (PFGE) indicated the epidemiological relationship. The outbreak strains, demonstrated genetic distinction between our three outbreaks and isolates from specific areas in the hospital.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12767845     DOI: 10.1016/s0195-6701(03)00076-8

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  15 in total

1.  Prevalence of group A streptococcal carriers in asymptomatic children and clonal relatedness among isolates in Malatya, Turkey.

Authors:  Riza Durmaz; Bengul Durmaz; Mehmet Bayraktar; Ibrahim Halil Ozerol; Mahmut Tayyar Kalcioglu; Elif Aktas; Zeynep Cizmeci
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

2.  Occurrence of OXA-58-like carbapenemases in Acinetobacter spp. collected over 10 years in three continents.

Authors:  Juliana Coelho; Neil Woodford; Mariya Afzal-Shah; David Livermore
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

3.  Control of an Acinetobacter [corrected] baumannii outbreak in a neonatal ICU without suspension of service: a devastating outbreak in Diyarbakir, Turkey.

Authors:  S Hosoglu; M Hascuhadar; E Yasar; S Uslu; B Aldudak
Journal:  Infection       Date:  2011-09-01       Impact factor: 3.553

4.  Antibiotic resistance and carriage class 1 and 2 integrons in clinical isolates of Acinetobacter baumannii from Tehran, Iran.

Authors:  Reza Mirnejad; Sepideh Mostofi; Faramaz Masjedian
Journal:  Asian Pac J Trop Biomed       Date:  2013-02

5.  Long-term control of hospital-wide, endemic multidrug-resistant Acinetobacter baumannii through a comprehensive "bundle" approach.

Authors:  Jesús Rodríguez-Baño; Lola García; Encarnación Ramírez; Luis Martínez-Martínez; Miguel A Muniain; Felipe Fernández-Cuenca; Margarita Beltrán; Juan Gálvez; Jose M Rodríguez; Carmen Velasco; Concepción Morillo; Federico Perez; Andrea Endimiani; Robert A Bonomo; Alvaro Pascual
Journal:  Am J Infect Control       Date:  2009-05-19       Impact factor: 2.918

6.  Nosocomial transmission of CTX-M-2 beta-lactamase-producing Acinetobacter baumannii in a neurosurgery ward.

Authors:  Noriyuki Nagano; Yukiko Nagano; Christophe Cordevant; Naohiro Shibata; Yoshichika Arakawa
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

7.  A 2000 patient retrospective assessment of a new strategy for burn wound management in view of infection prevention and treatment.

Authors:  Justyna Glik; Wojciech Łabuś; Diana Kitala; Karolina Mikuś-Zagórska; Christopher D Roberts; Mariusz Nowak; Aleksandra Kasperczyk; Marek Kawecki
Journal:  Int Wound J       Date:  2017-12-15       Impact factor: 3.315

8.  Antibiotic Resistance Profiles and Genotypes of Acinetobacter baumannii Isolates and In Vitro Interactions of Various Antibiotics in Combination with Tigecycline and Colistin.

Authors:  Ayça Büyük; Fethiye Ferda Yilmaz; Süreyya Gül Yurtsever; Mine Hoşgör Limoncu
Journal:  Turk J Pharm Sci       Date:  2017-04-15

9.  Multidrug-resistant Acinetobacter baumannii.

Authors:  Aharon Abbo; Shiri Navon-Venezia; Orly Hammer-Muntz; Tami Krichali; Yardena Siegman-Igra; Yehuda Carmeli
Journal:  Emerg Infect Dis       Date:  2005-01       Impact factor: 6.883

10.  Multidrug-resistant Acinetobacter extremity infections in soldiers.

Authors:  Kepler A Davis; Kimberly A Moran; C Kenneth McAllister; Paula J Gray
Journal:  Emerg Infect Dis       Date:  2005-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.